Copy
Twitter
LinkedIn

November 2020

MPCCC welcomes new cancer and community representatives to inform priorities

The MPCCC is delighted to welcome five new community members with lived experiences of cancer to its Advisory Group, whose multidisciplinary representatives will play a central role in providing strategic direction to the MPCCC. Continue reading »

Personalised cancer treatment gives hope to kids and adults alike

Dr Jason Cain’s laboratory at the Hudson Institute of Medical Research investigates lung cancer and paediatric cancers including brain tumours, to develop new treatments with fewer side effects. The team is specifically interested in studying the most insidious cancer types with low survival rates. Continue reading »

New plant-based gel to fast-track 'mini-organs' growth, improve cancer treatment

Monash University researchers have created the world’s first bioactive plant-based nanocellulose hydrogel to support organoid growth and help significantly reduce the costs of studies into cancer and COVID-19. Continue reading »

Australian-first study on new precision prostate cancer treatment

Epworth HealthCare, has partnered with Icon Cancer Centre, in a study to support a new precision prostate cancer treatment, that aims to reduce side effects to preserve the quality of life of patients. Continue reading »

Melanoma - know your risk

This year, the Victorian Melanoma Service (VMS) at The Alfred has seen a significant drop in referrals. But cases of melanoma have not dropped – prompting specialists to urge all Victorians to act now before it’s too late. Continue reading »

Stepping up our fight against Australia’s biggest cancer killer

Tegan Dunmall arrives as our Lung Cancer Care Coordinator, becoming a first port of call for our patients, to take them through their cancer journey at every step. “Many people think smoking is the only risk factor, when in fact the risks can be increased by occupational exposure, pollution and genetics as well." 
Continue reading »

Alfred Brain Bio-Bank brings hope for 22 year old patient with brain cancer

Alfred Health, 22-year-old patient, Demi Lawson has not only faced a global pandemic, but a diagnosis of brain cancer, with an awake craniotomy (brain surgery). Continue reading »

Register for 2020 SMICS Annual Forum

The Southern Melbourne Integrated Cancer Service (SMICS) 2020 Annual Forum 
“Ethical Considerations” will be held from 12.30-1.30pm on Monday 7 December 2020 featuring keynote speaker Professor Clare Delaney, addressing ethical considerations in cancer care during and beyond COVID-19.  We will also showcase the pilot of a newly developed radiological report to define resectability of non metastatic pancreatic ductal adenocarcenoma (PDAC) with Dr Charles Pilgrim and Associate Professor Samantha Ellis.

Register for forum

MRFF Emerging Priorities and Consumer Driven Research Initiative – 2020 Childhood Cancer Research Grant
This funding scheme aims to provide grants of financial assistance to support  medical research and medical innovation projects that improve our understanding of the aetiology, biology and progression of cancer in children and adolescents. $9 million is available in this funding pool, and applications close on 3rd February 2021Apply now »

MRFF Clinical Trial Activity Initiative - 2020 International Clinical Trial Collaborations Grant Opportunity 
Applicants to this funding scheme must propose a clinical trial in Australia, in collaboration with international counterparts. $12.6 million is available in this funding pool, and round 2 applications close on 3rd March 2020.  Apply now »

All those interested in applying for these grants can contact Karen McConalogue for application support on karen.mcconalogue@monash.edu.

Participate in the 2020 Repeat Prostate Cancer Summit

The Repeat Prostate Cancer Summit will provide an opportunity to explore changes in care since the initial 2016 summit and draw upon clinician and consumer expertise to identify priorities for improvement in Victoria.  We are fortunate to have access to data from the DHHS and the Prostate Cancer Outcomes Registry to share at the Summit.  It will be held on the following two dates online. Register here » 

Friday 4th December 2.30-4.30pm &

Friday 11th December 2.30-4.30pm

For queries, email: NEMICSAdmin@austin.org.au  or speak with Victorian Tumour Summits project manager Janine Scott on 0422 225 996.  

Cancer in Victoria - Statistics and Trends - 2019

The Victorian Cancer Registry (VCR) has released its latest publication Cancer in Victoria - Statistics and Trends - 2019. The VCR plays a vital role in providing cancer data, trends and analysis to stakeholders and the Victorian community. It is a compilation of the latest available Victorian cancer statistics, including detailed tables on cancer incidence, mortality and survival, and projections of incidence and mortality to 2034. 


The early pages of the report include a brief overview of cancer in Victoria in 2019, and a selection of easily interpretable infographics and graphs which may be reproduced in your own reports and presentations. Download report » 

Watch MPCCC Tech Talk:
Dr Nick Wong

Dr Nick Wong discusses NGS at scale : Considerations when designing a High Throughput Genomic Assay for the ASPREE Study in  this Tech Talk. Watch now » 

Watch the MPCCC Award for Outstanding Cancer Research in Victoria: Winners' Seminar

A/Prof Renea Taylor and Dr Pouya Faridi discuss their winning research and their career progression in this seminar. Watch now » 

MPCCC Precision Oncology Seminar: Professor Tony Purcell

Watch MPCCC Precision Oncology Seminar: Prof Tony Purcell

Prof Tony Purcell shares insights into the tumour immunopeptidome and its role in personalized immunotherapy in this seminar. Watch now » 

Watch MPCCC Tech Talk:
Dr Bernie Pope

Dr Bernie Pope discusses Somatic variant calling in whole genome sequencing, opportunities, challenges and solutions in this Tech Talk. Watch now » 

Providing optimal care for patients with gynaecological cancers
When: 7.30-8.30pm,
Tuesday 1 December
More information and registration

Practical Genomics for Oncology Trainees
When: 4.30-6.30pm
Wednesday 2 December
More information and registration

SMICS 2019-2020 Annual Forum
When: 12.30-1.30pm
Monday 7 December
More information and registration
A Shared Vision: Consumer Engagement in Research
When: 10.00am-12.00pm
Wednesday 9 December
More information and registration

Patient-reported outcome systems in routine clinical care: key steps in the roadmap to implementation
When: 1.00-2.00pm,
Monday 14 December
More information and registration

Teletrials: implementation of a new paradigm for clinical trials. Read article »

Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer. Read article »

Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma. Read article »

A single-domain bispecific antibody targeting CD1d and the NKT T-cell receptor induces a potent antitumor response. Read article »

Immunopeptidomic Analysis Reveals That Deamidated HLA-bound Peptides Arise Predominantly from Deglycosylated Precursor. Read article »

Monash Partners Comprehensive Cancer Consortium (MPCCC) is a strategic alliance of health service and research organisations working in partnership to improve cancer outcomes through integrated, collaborative and innovative research, service improvement and clinical care programs. We are a consortium made up of clinical, research and allied partner organisations. 
Clinical partners
Alfred Health; Monash Health; Eastern Health; Peninsula Health; 
Cabrini Health; Epworth HealthCare

Research partners
Monash University; Hudson Institute of Medical Research

Allied partners
Southern Melbourne Integrated Cancer Service (SMICS); 
Monash Partners Academic Health Science Centre (Monash Partners).
Twitter
LinkedIn
If you would like to contribute to the MPCCC e-Newsletter email info@monashpartnersccc.org
Copyright © 2020 MPCCC, All rights reserved.